These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 15761222)
1. Initial safety experience of abciximab and heparin for acute ischemic stroke. Mandava P; Lick SD; Rahman MA; Langsjoen H; Reddy KV; Nelson J; Kent TA Cerebrovasc Dis; 2005; 19(4):276-8. PubMed ID: 15761222 [No Abstract] [Full Text] [Related]
2. MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window. Mitsias PD; Lu M; Silver B; Morris D; Ewing JR; Daley S; Lewandowski C; Katramados A; Papamitsakis NI; Ebadian HB; Zhao Q; Soltanian-Zadeh H; Hearshen D; Patel SC; Chopp M Neurology; 2005 Aug; 65(4):612-5. PubMed ID: 16116128 [TBL] [Abstract][Full Text] [Related]
3. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Adams HP; Effron MB; Torner J; Dávalos A; Frayne J; Teal P; Leclerc J; Oemar B; Padgett L; Barnathan ES; Hacke W; Stroke; 2008 Jan; 39(1):87-99. PubMed ID: 18032739 [TBL] [Abstract][Full Text] [Related]
4. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS. Lenderink T; Boersma E; Ruzyllo W; Widimsky P; Ohman EM; Armstrong PW; Wallentin L; Simoons ML; Am Heart J; 2004 May; 147(5):865-73. PubMed ID: 15131544 [TBL] [Abstract][Full Text] [Related]
5. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA). Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744 [TBL] [Abstract][Full Text] [Related]
6. Rescue treatment with abciximab in acute ischemic stroke. Lee KY; Heo JH; Lee SI; Yoon PH Neurology; 2001 Jun; 56(11):1585-7. PubMed ID: 11402123 [TBL] [Abstract][Full Text] [Related]
7. Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia. Lee CL; Colombo PC; Eisenberger A; Diuguid D; Jennings DL; Han J; Salna MP; Takeda K; Kurlansky PA; Yuzefpolskaya M; Garan AR; Naka Y; Takayama H Ann Thorac Surg; 2018 Jan; 105(1):122-128. PubMed ID: 28987395 [TBL] [Abstract][Full Text] [Related]
8. Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials. Blankenship JC; Balog C; Sapp SK; Califf RM; Lincoff AM; Tcheng JE; Topol EJ Catheter Cardiovasc Interv; 2002 Dec; 57(4):476-83. PubMed ID: 12455081 [TBL] [Abstract][Full Text] [Related]
9. MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window. Mandava P; Anderson JA; Kent TA Neurology; 2006 Apr; 66(7):1132. PubMed ID: 16606946 [No Abstract] [Full Text] [Related]
10. Right atrial thrombus treated successfully with abciximab and heparin. Borges AC; Reibis RK; Claus M; Baumann G J Thromb Thrombolysis; 2001 Dec; 12(3):283-7. PubMed ID: 11981111 [TBL] [Abstract][Full Text] [Related]
11. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment. Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of low-dose unfractionated heparin during percutaneous coronary revascularisation and the relationship between activated clotting time and haemorrhagic or ischaemic complications: our results. Capuano C; Sesana M; Leonzi O; Cuccia C J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):866-71. PubMed ID: 17122672 [TBL] [Abstract][Full Text] [Related]